NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.

Activation of CD40 is essential for thymus-dependent humoral immune responses and rescuing B cells from apoptosis. Many of the effects of CD40 are believed to be achieved through altered gene expression. In addition to Bcl-x, a known CD40-regulated antiapoptotic molecule, we identified a related antiapoptotic molecule, A1/Bfl-1, as a CD40-inducible gene. Inhibition of the NF-kappaB pathway by overexpression of a dominant-active inhibitor of NF-kappaB abolished CD40-induced up-regulation of both the Bfl-1 and Bcl-x genes and also eliminated the ability of CD40 to rescue Fas-induced cell death. Within the upstream promoter region of Bcl-x, a potential NF-kappaB-binding sequence was found to support NF-kappaB-dependent transcriptional activation. Furthermore, expression of physiological levels of Bcl-x protected B cells from Fas-mediated apoptosis in the absence of NF-kappaB signaling. Thus, our results suggest that CD40-mediated cell survival proceeds through NF-kappaB-dependent up-regulation of Bcl-2 family members.

[1]  M Hubank,et al.  Identifying differences in mRNA expression by representational difference analysis of cDNA. , 1994, Nucleic acids research.

[2]  H. Lorenz,et al.  A rapid and simple method for the isolation of apoptotic DNA fragments. , 1994, Nucleic acids research.

[3]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[4]  R. Flavell,et al.  CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.

[5]  I. Park,et al.  Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines. , 1997, Anticancer research.

[6]  J. Banchereau,et al.  The CD40 antigen and its ligand. , 1994, Annual review of immunology.

[7]  S. Gerondakis,et al.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. , 1999, Genes & development.

[8]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[9]  T. Rothstein.  Signals and susceptibility to programmed death in b cells. , 1996, Current opinion in immunology.

[10]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[11]  J. Karras,et al.  Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. , 1995, Journal of immunology.

[12]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[13]  Fred Wong,et al.  Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. , 1998 .

[14]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[15]  W. Zong,et al.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .

[16]  P. Krammer,et al.  Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis , 1996, The Journal of experimental medicine.

[17]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[18]  A. Krikos,et al.  Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. , 1992, The Journal of biological chemistry.

[19]  M. Kehry,et al.  CD40-mediated signaling in B cells. Balancing cell survival, growth, and death. , 1996, Journal of immunology.

[20]  R. Callard,et al.  CD40 ligand and its role in X-linked hyper-IgM syndrome. , 1993, Immunology today.

[21]  Z. Ao,et al.  IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival , 1998 .

[22]  D. Baltimore,et al.  Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Fortune,et al.  Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. , 1995, Journal of immunology.

[24]  S. Nelson,et al.  Characterization of transformation related genes in oral cancer cells , 1998, Oncogene.

[25]  G. Núñez,et al.  Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. , 1995, Journal of immunology.

[26]  M. Malim,et al.  Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Chinnadurai,et al.  Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities , 1998, Oncogene.

[28]  N. Yoshida,et al.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. , 1994, Immunity.

[29]  A. Karsan,et al.  Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. , 1996, Blood.

[30]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[31]  R. Flavell,et al.  Mice deficient for the CD40 ligand. , 1994, Immunity.

[32]  Jing Wu,et al.  B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40 , 1993, Nature.

[33]  C. Thompson,et al.  The role of bcl‐xL in CD40‐mediated rescue from anti‐μ‐induced apoptosis in WEHI‐231 B lymphoma cells , 1995, European journal of immunology.

[34]  M. Berger,et al.  Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.

[35]  G. Núñez,et al.  Bcl-x protects primary B cells against Fas-mediated apoptosis. , 1997, Journal of immunology.

[36]  G. Nolan,et al.  The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.

[37]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[38]  John Calvin Reed,et al.  Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. , 1996, Cellular immunology.

[39]  R. Noelle,et al.  The role of CD40 in the regulation of humoral and cell-mediated immunity. , 1994, Immunology today.

[40]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.